Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new pentasa clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on pentasa
- Prevention of Recurrence of Diverticulitis
Status: Recruiting, Condition Summary: Diverticulitis - Strategies in Maintenance for Patients Receiving Long-Term Therapy" (S.I.M.P.L.E.)
Status: Active, not recruiting, Condition Summary: Ulcerative Colitis - Prevention of Recurrence of Diverticulitis
Status: Recruiting, Condition Summary: Diverticulitis - Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.
Status: Completed, Condition Summary: Colitis, Ulcerative - Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
Status: Recruiting, Condition Summary: Diverticulitis - Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
Status: Recruiting, Condition Summary: Collagenous Colitis - Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
Status: Completed, Condition Summary: Crohn's Disease - Crohn's Disease Stem Cell Transplantation
Status: Recruiting, Condition Summary: Crohn's Disease - Randomized Placebo Controlled Trial of Budesonide-MMX™ (CB-01-02) 6 mg and 9 mg in Patients With Ulcerative Colitis
Status: Not yet recruiting, Condition Summary: Ulcerative Colitis - Asacol Acute Diverticulitis(DIVA)Study
Status: Recruiting, Condition Summary: Diverticulitis - A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease
Status: Terminated, Condition Summary: Crohn Disease - A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
Status: Terminated, Condition Summary: Colitis, Ulcerative - Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
Status: Recruiting, Condition Summary: Colitis, Ulcerative - Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease
Status: Recruiting, Condition Summary: Diverticulosis, Colonic - Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
Status: Recruiting, Condition Summary: Ulcerative Colitis - Dose Escalation and Remission (DEAR)
Status: Not yet recruiting, Condition Summary: Ulcerative Colitis - A Comparison of Once a Day Dose Compared to 2 Doses/Day
Status: Recruiting, Condition Summary: Ulcerative Colitis - Monoclonal Antibody Treatment of Crohn's Disease
Status: Completed, Condition Summary: Crohn's Disease - SONIC Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease
Status: Active, not recruiting, Condition Summary: Crohn's Disease - Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis
Status: Completed, Condition Summary: Colitis, Ulcerative - PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers
Status: Active, not recruiting, Condition Summary: Healthy - Mesalazine Therapy in Patients With Irritable Bowel Syndrome
Status: Active, not recruiting, Condition Summary: Irritable Bowel Syndrome - Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis
Status: Recruiting, Condition Summary: Ulcerative Colitis - New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis
Status: Completed, Condition Summary: Ulcerative Colitis - Asacol Dosing Study for Active Ulcerative Colitis
Status: Completed, Condition Summary: Ulcerative Colitis - Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
Status: Completed, Condition Summary: Ulcerative Colitis - Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
Status: Completed, Condition Summary: Ulcerative Colitis - Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
Status: Terminated, Condition Summary: Ulcerative Colitis - Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease
Status: Recruiting, Condition Summary: Crohn's Disease - A Double Blind Study for the Treatment of Acute Ulcerative Colitis
Status: Completed, Condition Summary: Ulcerative Colitis
